FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in Boston, Massachusetts

Biotech startups that raised Series A in Boston, Massachusetts

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in Boston, Massachusetts
One-time CSV
  • 57 funded companies, 51 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~boston-massachusetts.csv57 rows × 18 columns
CompanyCityLast roundAmountDate
Dash BioBostonSeries A$30.0M2026-08-03
Third Arc BioBostonSeries A$52.0M2026-02-04
NeurableBostonSeries A$35.0M2025-12-19
AI ProteinsBostonSeries A$42.5M2025-11-19
Predicta BiosciencesBostonSeries A$23.4M2025-10-01
Folia HealthBostonSeries A$10.5M2025-10-01
Freya BiosciencesBostonSeries A$11.8M2024-11-19
Averna TherapeuticsBostonSeries A$85.0M2024-06-25

8 rows of the CSV in 5 of its 18 columns.

57
Startups
$2.8B
Total raised
13
Funded in the last 12 months
$672.6M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

8 of 57
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024
Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
Folia Health Folia Health is a platform that securely captures and shares users' health and symptom data. Biotech Series A $10.5M 2025-10-01 $17.4M MassChallenge, Social Starts, Bantam Group +2 11 to 50 2016
Adaptilens Adaptilens develops an accommodating intraocular lens for cataract patients. Biotech Series A $17.5M 2024-04-29 $19.1M MassChallenge, Pillar VC, Perceptive Advisors +2 1 to 10 2019
Ascidian Therapeutics Ascidian Therapeutics is a biotechnology company focused on medical and clinical gene therapy. Biotech Series A $40.0M 2023-11-08 $90.0M Apple Tree Partners 11 to 50 2020
Orbita Orbita sells voice-first and conversational AI software that helps patients engage with digital healthcare. Artificial intelligence Series A $9.0M 2020-05-27 $16.5M MassChallenge, nvp capital, Cultivation Capital +2 11 to 50 2015

Table 1. Biotech startups that raised Series A in Boston, Massachusetts: the 8 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 57.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Third Arc Bio Third Arc Bio develops multifunctional antibodies for inflammatory and immunology diseases. Biotech Series A $52.0M 2026-02-04 $217.0M T. Rowe Price, Cormorant Asset Management, Foresite Capital +1 11 to 50 2022
2 AI Proteins AI Proteins designs and engineers miniprotein therapeutics using artificial intelligence. Artificial intelligence Series A $42.5M 2025-11-19 $80.4M Intel Ignite, Lightchain Capital, Cobro Ventures 11 to 50 2021
3 Neurable Neurable develops AI tools for translating brain signals and brain-computer interface technology. Artificial intelligence Series A $35.0M 2025-12-19 $57.3M National Science Foundation, Global Brain Corporation, Metaplanet +1 11 to 50 2015
4 Dash Bio Dash Bio develops automated laboratory workflows and software to support drug development through bioanalysis services. Artificial intelligence Series A $30.0M 2026-08-03 $47.5M Freestyle Capital, Swift Ventures, LifeX Ventures +1 11 to 50 2024

Table 2. Biotech startups that raised Series A in Boston, Massachusetts: the 4 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 MassChallenge Startup accelerator Boston, United States 3 5%
2 firedrop Micro VC fund London, United Kingdom 1 2% 1 Dash Bio
3 LifeX Ventures Venture capital firm New York, United States 1 2% 1 Dash Bio
4 Swift Ventures Venture capital firm Lafayette, United States 1 2% 1 Dash Bio
5 Freestyle Capital Venture capital firm San Francisco, United States 1 2% 1 Dash Bio
6 Cormorant Asset Management Hedge fund Boston, United States 1 2% 1 Third Arc Bio
7 T. Rowe Price Private equity firm Baltimore, United States 1 2% 1 Third Arc Bio
8 AbbVie Corporate venture arm North Chicago, United States 1 2% 1 Third Arc Bio
9 Foresite Capital Private equity firm San Francisco, United States 1 2% 1 Third Arc Bio
10 Metaplanet Venture capital firm Tallinn, Estonia 1 2% 1 Neurable
11 National Science Foundation Entrepreneurship program Alexandria, United States 1 2% 1 Neurable
12 M Ventures Corporate venture arm Amsterdam, The Netherlands 1 2% 1 Neurable
13 Global Brain Corporation Venture capital firm Tokyo, Japan 1 2% 1 Neurable
14 Intel Ignite Startup accelerator Tel Aviv, Israel 1 2% 1 AI Proteins
15 Cobro Ventures Private equity firm Arlington, United States 1 2% 1 AI Proteins

Table 3. Biotech startups that raised Series A in Boston, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 48 84% $2.4B
Software 11 19% $354.8M
Artificial intelligence 9 16% $307.4M
Hardware 3 5% $121.8M
Commerce 1 2% $17.0M
Energy 1 2% $5.8M

Table 4. Biotech startups that raised Series A in Boston, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 57 100% $34.0M

Table 5. Biotech startups that raised Series A in Boston, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 8% $11.5M
October 2026 1 8% $30.0M
September 2026 2 15% $235.0M
August 2026 1 8% $30.0M
June 2026 2 15% $46.6M
February 2026 1 8% $52.0M
January 2026 1 8% $80.0M
December 2025 2 15% $55.0M
November 2025 2 15% $132.5M

Table 6. Biotech startups that raised Series A in Boston, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 9 16% $485.1M
2025 9 16% $506.4M
2024 7 12% $367.0M
2023 5 9% $85.6M
2022 4 7% $117.0M
2021 6 11% $228.1M

Table 7. Biotech startups that raised Series A in Boston, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 9 16%
2020 to 2022 16 29%
2015 to 2019 23 41%
2010 to 2014 5 9%
Before 2010 3 5%

Table 8. Biotech startups that raised Series A in Boston, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 17 30%
11 to 50 36 63%
51 to 100 1 2%
101 to 250 2 4%
251 to 500 1 2%

Table 9. Biotech startups that raised Series A in Boston, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Boston, Massachusetts whose last round is Series A are on the list?
57, in the file dated 16 November 2026. 13 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 57 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in Boston, Massachusetts: 57 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Boston

Other sectors that raised Series A in Boston

Cite: FundingWatcher, 57 biotech companies in Boston, Massachusetts whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/boston-massachusetts/